Guohui Xu
Academic / Other · 1 registered clinical trial — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | TACE Plus Camrelizumab and Apatinib for Unresectable Hepatocellular Carcinoma Unresectable Hepatocellular Carcinoma, Transarterial Chemoembolization, Camrelizumab | Phase 3 | 2024-08-10 |